Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T22:31:45.566Z.
Calculation as of: 2026-10-06T22:31:45.566Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a99f3f088f54f9f9c0225e5104dac3e52b54f392bb47ad8d1f9af79329b73e7d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Edgewise Therapeutics, Inc.
Market Cap
$4.31B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.31B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.37B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.48B
EV/EBITDA Ratio
8.94x
TTM Avg
11.30x
3Y Avg
25.94x
5Y Avg
24.40x
Market Cap
$4.02B
EV/EBITDA Ratio
N/A
TTM Avg
8.40x
3Y Avg
13.30x
5Y Avg
13.30x
Market Cap
$4.60B
EV/EBITDA Ratio
75.40x
TTM Avg
416.98x
3Y Avg
416.98x
5Y Avg
416.98x
Market Cap
$3.99B
EV/EBITDA Ratio
13.66x
TTM Avg
16.01x
3Y Avg
14.76x
5Y Avg
19.10x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.31B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.31B | N/A | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | 8.94x | 11.30x | 25.94x | 24.40x |
| LivaNova PLC (LIVN)vs › | $4.12B | 16.17x | 14.83x | 60.35x | 57.23x |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.11B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | N/A | 8.40x | 13.30x | 13.30x |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 75.40x | 416.98x | 416.98x | 416.98x |
| ICU Medical, Inc. (ICUI)vs › | $3.99B | 13.66x | 16.01x | 14.76x | 19.10x |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 13.96x | 13.23x | 15.13x | 17.95x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
